
Christopher Brian Mckinley
Examiner (ID: 13265)
| Most Active Art Unit | 3781 |
| Art Unit(s) | 3781 |
| Total Applications | 591 |
| Issued Applications | 270 |
| Pending Applications | 9 |
| Abandoned Applications | 315 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18413095
[patent_doc_number] => 11667628
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-06
[patent_title] => Compounds for imaging tau proteins that accumulate in brain
[patent_app_type] => utility
[patent_app_number] => 17/477479
[patent_app_country] => US
[patent_app_date] => 2021-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 35
[patent_no_of_words] => 30624
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17477479
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/477479 | Compounds for imaging tau proteins that accumulate in brain | Sep 15, 2021 | Issued |
Array
(
[id] => 17312966
[patent_doc_number] => 20210402014
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => COMPLEX POLYSACCHARIDE-BOUND RADIOISOTOPE CHELATES AND METHODS OF TREATING MALIGNANCIES THEREWITH
[patent_app_type] => utility
[patent_app_number] => 17/474916
[patent_app_country] => US
[patent_app_date] => 2021-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3055
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17474916
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/474916 | COMPLEX POLYSACCHARIDE-BOUND RADIOISOTOPE CHELATES AND METHODS OF TREATING MALIGNANCIES THEREWITH | Sep 13, 2021 | Abandoned |
Array
(
[id] => 19431102
[patent_doc_number] => 20240299600
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-12
[patent_title] => METHOD FOR TREATING ACUTE MYELOID LEUKEMIA USING VENETOCLAX IN CONJUNCTION WITH LINTUZUMAB-AC225
[patent_app_type] => utility
[patent_app_number] => 18/044356
[patent_app_country] => US
[patent_app_date] => 2021-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11867
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18044356
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/044356 | METHOD FOR TREATING ACUTE MYELOID LEUKEMIA USING VENETOCLAX IN CONJUNCTION WITH LINTUZUMAB-AC225 | Sep 6, 2021 | Pending |
Array
(
[id] => 17384018
[patent_doc_number] => 20220031870
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => METAL COMPLEXES AND FLUORINATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/395319
[patent_app_country] => US
[patent_app_date] => 2021-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9190
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17395319
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/395319 | METAL COMPLEXES AND FLUORINATION THEREOF | Aug 4, 2021 | Abandoned |
Array
(
[id] => 19310498
[patent_doc_number] => 12036292
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-16
[patent_title] => Heterobiaryl compounds and imaging agents for imaging huntingtin protein
[patent_app_type] => utility
[patent_app_number] => 17/395055
[patent_app_country] => US
[patent_app_date] => 2021-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24310
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17395055
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/395055 | Heterobiaryl compounds and imaging agents for imaging huntingtin protein | Aug 4, 2021 | Issued |
Array
(
[id] => 17687612
[patent_doc_number] => 20220194904
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => 18F-LABELED TRIAZOLE CONTAINING PSMA INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/390284
[patent_app_country] => US
[patent_app_date] => 2021-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19188
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17390284
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/390284 | 18F-LABELED TRIAZOLE CONTAINING PSMA INHIBITORS | Jul 29, 2021 | Pending |
Array
(
[id] => 17342232
[patent_doc_number] => 20220008563
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => RADIOLABELLED AND NONRADIOLABELLED PEGYLATED COMPOUNDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/372410
[patent_app_country] => US
[patent_app_date] => 2021-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16370
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 168
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17372410
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/372410 | RADIOLABELLED AND NONRADIOLABELLED PEGYLATED COMPOUNDS AND USES THEREOF | Jul 8, 2021 | Abandoned |
Array
(
[id] => 17334703
[patent_doc_number] => 20220001034
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => NOVEL FORMULATION AND METHOD OF SYNTHESIS
[patent_app_type] => utility
[patent_app_number] => 17/366681
[patent_app_country] => US
[patent_app_date] => 2021-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5580
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17366681
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/366681 | NOVEL FORMULATION AND METHOD OF SYNTHESIS | Jul 1, 2021 | Abandoned |
Array
(
[id] => 17291034
[patent_doc_number] => 20210386873
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-16
[patent_title] => PRECURSOR COMPOUND OF RADIOACTIVE HALOGEN-LABELED ORGANIC COMPOUND
[patent_app_type] => utility
[patent_app_number] => 17/356757
[patent_app_country] => US
[patent_app_date] => 2021-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4642
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17356757
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/356757 | PRECURSOR COMPOUND OF RADIOACTIVE HALOGEN-LABELED ORGANIC COMPOUND | Jun 23, 2021 | Abandoned |
Array
(
[id] => 18853885
[patent_doc_number] => 11851446
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-26
[patent_title] => Probes for imaging Huntingtin protein
[patent_app_type] => utility
[patent_app_number] => 17/353627
[patent_app_country] => US
[patent_app_date] => 2021-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18477
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17353627
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/353627 | Probes for imaging Huntingtin protein | Jun 20, 2021 | Issued |
Array
(
[id] => 19310497
[patent_doc_number] => 12036291
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-16
[patent_title] => Probes for imaging huntingtin protein
[patent_app_type] => utility
[patent_app_number] => 17/353611
[patent_app_country] => US
[patent_app_date] => 2021-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12085
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17353611
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/353611 | Probes for imaging huntingtin protein | Jun 20, 2021 | Issued |
Array
(
[id] => 17291035
[patent_doc_number] => 20210386874
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-16
[patent_title] => COMPOSITIONS AND METHODS FOR MEASURING OXIDATIVE STRESS
[patent_app_type] => utility
[patent_app_number] => 17/344739
[patent_app_country] => US
[patent_app_date] => 2021-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13070
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17344739
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/344739 | Compositions and methods for measuring oxidative stress | Jun 9, 2021 | Issued |
Array
(
[id] => 19011761
[patent_doc_number] => 11918662
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-05
[patent_title] => Heterocyclic compounds and imaging agents for imaging huntingtin protein
[patent_app_type] => utility
[patent_app_number] => 17/344582
[patent_app_country] => US
[patent_app_date] => 2021-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52193
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17344582
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/344582 | Heterocyclic compounds and imaging agents for imaging huntingtin protein | Jun 9, 2021 | Issued |
Array
(
[id] => 17080691
[patent_doc_number] => 20210275697
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => MONO-, DI- OR POLYSACCHARIDE USED AS METAL INHIBITOR IN THE PREPARATION OF 68GA-CHELATE-FUNCTIONALIZED TARGETING AGENT
[patent_app_type] => utility
[patent_app_number] => 17/325258
[patent_app_country] => US
[patent_app_date] => 2021-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4541
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17325258
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/325258 | MONO-, DI- OR POLYSACCHARIDE USED AS METAL INHIBITOR IN THE PREPARATION OF 68GA-CHELATE-FUNCTIONALIZED TARGETING AGENT | May 19, 2021 | Pending |
Array
(
[id] => 19563569
[patent_doc_number] => 12138320
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-12
[patent_title] => Composition and methods for tumor imaging and treatment
[patent_app_type] => utility
[patent_app_number] => 17/317529
[patent_app_country] => US
[patent_app_date] => 2021-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 33
[patent_no_of_words] => 17183
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17317529
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/317529 | Composition and methods for tumor imaging and treatment | May 10, 2021 | Issued |
Array
(
[id] => 17156023
[patent_doc_number] => 20210317074
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-14
[patent_title] => HISTONE ACETYLTRANSFERASE ACTIVATORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/317133
[patent_app_country] => US
[patent_app_date] => 2021-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53459
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17317133
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/317133 | HISTONE ACETYLTRANSFERASE ACTIVATORS AND USES THEREOF | May 10, 2021 | Abandoned |
Array
(
[id] => 18019149
[patent_doc_number] => 20220370648
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => METHODS AND MATERIALS FOR MAKING PET RADIOTRACERS
[patent_app_type] => utility
[patent_app_number] => 17/314366
[patent_app_country] => US
[patent_app_date] => 2021-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4968
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17314366
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/314366 | METHODS AND MATERIALS FOR MAKING PET RADIOTRACERS | May 6, 2021 | Abandoned |
Array
(
[id] => 17183939
[patent_doc_number] => 20210330824
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-28
[patent_title] => PURIFICATION METHOD AND COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/314158
[patent_app_country] => US
[patent_app_date] => 2021-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9740
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17314158
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/314158 | PURIFICATION METHOD AND COMPOSITIONS | May 6, 2021 | Abandoned |
Array
(
[id] => 17095486
[patent_doc_number] => 20210283277
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => TAU PET IMAGING LIGANDS
[patent_app_type] => utility
[patent_app_number] => 17/246184
[patent_app_country] => US
[patent_app_date] => 2021-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9577
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17246184
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/246184 | TAU PET IMAGING LIGANDS | Apr 29, 2021 | Abandoned |
Array
(
[id] => 18404629
[patent_doc_number] => 20230165980
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-01
[patent_title] => METHODS FOR RADIOLABELING PSMA BINDING LIGANDS AND THEIR KITS
[patent_app_type] => utility
[patent_app_number] => 17/997299
[patent_app_country] => US
[patent_app_date] => 2021-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10807
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17997299
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/997299 | METHODS FOR RADIOLABELING PSMA BINDING LIGANDS AND THEIR KITS | Apr 27, 2021 | Pending |